Considering that FGF23 is unable to normalize serum Pi levels in hyperparathyroidism and that inactivating mutations of FGF23 cause hyperphosphatemia despite the presence of PTH (34), both hormones appear to be necessary to maintain Pi homeostasis. The gene discussed is FGF23; the disease is hyperphosphatemia.